[breadcrumb_custom]

Tag: Hologic Inc.

Industry

Is Hologic Inc. (NASDAQ:HOLX) Still Worth A Bite?

Hologic Inc. (NASDAQ:HOLX) has a beta of 1.17, a 12-month trailing P/E ratio of 8.59, and a growth ratio of 3.66. The stock’s Relative Strength

Companies

HOLX Stock: Hologic Inc. (NASDAQ:HOLX) Is Still Worth a Bite

Hologic Inc. (NASDAQ:HOLX) has a beta of 1.17, a 12-month trailing P/E ratio of 8.70, and a growth ratio of 3.70. The stock’s Relative Strength

Industry

Are Hologic Inc. (NASDAQ:HOLX) Prospects Worsening?

Hologic Inc. (NASDAQ:HOLX) has a beta of 1.18, a 12-month trailing P/E ratio of 8.33, and a growth ratio of 3.55. The stock’s Relative Strength

Industry

Analyst’s Sets Hologic Inc. (NASDAQ:HOLX) New Target at $84.17: HOLX is Now On A Buy List

Hologic Inc. (NASDAQ:HOLX) previous close was $63.29 while the outstanding shares total 258.47M. The firm has a beta of 1.17, a 12-month trailing P/E ratio

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: Hologic Inc.

Is Hologic Inc. (NASDAQ:HOLX) Still Worth A Bite?

HOLX Stock: Hologic Inc. (NASDAQ:HOLX) Is Still Worth a Bite

Are Hologic Inc. (NASDAQ:HOLX) Prospects Worsening?

Analyst’s Sets Hologic Inc. (NASDAQ:HOLX) New Target at $84.17: HOLX is Now On A Buy List

Quick Links

Categories